VSNL1 Monoclonal antibody

VSNL1 Monoclonal Antibody for WB, IHC, ELISA
Cat No. 67134-1-Ig

产品说明书

CloneNo. 2C6C3

宿主/亚型

Mouse / IgG1

种属反应性

Human, mouse, rat, pig and More (1)

应用

WB, IHC, ELISA

Hippocalcin like protein 3, HLP3, HPCAL3, HUVISL1, VILIP, VILIP 1, visinin like 1, Visinin like protein 1, VISL1, VLP 1, VSNL1

缓冲液配方:  PBS and Azide
PBS and Azide
PBS Only
偶联物:  Unconjugated
Unconjugated
规格: 

-/ -


经过测试的应用

Positive WB detected inhuman brain tissue, rat brain tissue, mouse brain tissue
Positive IHC detected inmouse brain tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

推荐稀释比

应用推荐稀释比
Western Blot (WB)WB : 1:1000-1:6000
Immunohistochemistry (IHC)IHC : 1:150-1:600
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

发表文章中的应用

IHCSee 1 publications below

产品信息

67134-1-Ig targets VSNL1 in WB, IHC, ELISA applications and shows reactivity with Human, mouse, rat, pig samples.

经测试应用 WB, IHC, ELISA Application Description
文献引用应用IHC
经测试反应性 Human, mouse, rat, pig
文献引用反应性human
免疫原 VSNL1 fusion protein Ag4923 种属同源性预测
宿主/亚型 Mouse / IgG1
抗体类别 Monoclonal
产品类型 Antibody
全称 visinin-like 1
别名 Hippocalcin like protein 3, HLP3, HPCAL3, HUVISL1, VILIP, VILIP 1, visinin like 1, Visinin like protein 1, VISL1, VLP 1, VSNL1
计算分子量 22 kDa
观测分子量 20 kDa
GenBank蛋白编号BC022012
基因名称 VSNL1
Gene ID (NCBI) 7447
RRIDAB_2882433
偶联类型 Unconjugated
形式 Liquid
纯化方式Protein G purification
UNIPROT IDP62760
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Aliquoting is unnecessary for -20oC storage.

实验方案

Product Specific Protocols
WB protocol for VSNL1 antibody 67134-1-IgDownload protocol
IHC protocol for VSNL1 antibody 67134-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols

发表文章

SpeciesApplicationTitle
humanIHC

Biomedicines

Characteristic Analysis of Featured Genes Associated with Cholangiocarcinoma Progression

Authors - Qigu Yao
Loading...